학술논문

Pembrolizumab-triggered Uveitis: An Additional Surrogate Marker for Responders in Melanoma Immunotherapy?
Document Type
Article
Source
Journal of Immunotherapy; Nov/Dec2016, Vol. 39 Issue 9, p379-382, 4p
Subject
Language
ISSN
15249557